dr. martens plc - DOCMF

DOCMF

Close Chg Chg %
1.01 0.05 4.50%

Open Market

1.06

+0.05 (4.50%)

Volume: 3.95K

Last Updated:

Jul 1, 2025, 12:39 PM EDT

Company Overview: dr. martens plc - DOCMF

DOCMF Key Data

Open

$1.05

Day Range

1.05 - 1.06

52 Week Range

0.62 - 1.16

Market Cap

$1.00B

Shares Outstanding

964.49M

Public Float

559.84M

Beta

0.87

Rev. Per Employee

N/A

P/E Ratio

173.33

EPS

N/A

Yield

224.05%

Dividend

$0.02

EX-DIVIDEND DATE

Aug 29, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

20.53K

 

DOCMF Performance

1 Week
 
4.50%
 
1 Month
 
-4.92%
 
3 Months
 
67.74%
 
1 Year
 
10.05%
 
5 Years
 
N/A
 

DOCMF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About dr. martens plc - DOCMF

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.

DOCMF At a Glance

Dr. Martens Plc
28 Jamestown Road
London, Greater London NW1 7BY
Phone 44-121-415-7047 Revenue 1.00B
Industry Apparel/Footwear Net Income 5.74M
Sector Consumer Non-Durables Employees 2,348
Fiscal Year-end 03 / 2026
View SEC Filings

DOCMF Valuation

P/E Current 173.333
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 109.606
Price to Sales Ratio 0.638
Price to Book Ratio 1.34
Price to Cash Flow Ratio 2.986
Enterprise Value to EBITDA 5.633
Enterprise Value to Sales 0.953
Total Debt to Enterprise Value 0.541

DOCMF Efficiency

Revenue/Employee 427,903.461
Income Per Employee 2,444.852
Receivables Turnover 12.761
Total Asset Turnover 0.854

DOCMF Liquidity

Current Ratio 2.591
Quick Ratio 1.409
Cash Ratio 0.983

DOCMF Profitability

Gross Margin 55.739
Operating Margin 7.694
Pretax Margin 1.117
Net Margin 0.571
Return on Assets 0.488
Return on Equity 1.224
Return on Total Capital 0.579
Return on Invested Capital 0.595

DOCMF Capital Structure

Total Debt to Total Equity 109.634
Total Debt to Total Capital 52.298
Total Debt to Total Assets 45.145
Long-Term Debt to Equity 97.107
Long-Term Debt to Total Capital 46.322
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Dr. Martens Plc - DOCMF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.24B 1.20B 1.10B 1.00B
Sales Growth
+22.90% -2.97% -8.45% -8.82%
Cost of Goods Sold (COGS) incl D&A
500.17M 525.14M 470.13M 444.70M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
50.13M 65.22M 90.83M 92.74M
Depreciation
43.71M 55.11M 83.55M 84.96M
Amortization of Intangibles
6.42M 10.11M 7.29M 7.78M
COGS Growth
+13.86% +4.99% -10.48% -5.41%
Gross Income
740.43M 678.57M 631.82M 560.02M
Gross Income Growth
+29.87% -8.35% -6.89% -11.36%
Gross Profit Margin
+59.68% +56.37% +57.34% +55.74%
2022 2023 2024 2025 5-year trend
SG&A Expense
422.59M 448.97M 473.02M 482.71M
Research & Development
- - - -
-
Other SG&A
422.59M 448.97M 473.02M 482.71M
SGA Growth
+35.57% +6.24% +5.36% +2.05%
Other Operating Expense
- - - -
-
Unusual Expense
- 273.17K 4.69M 26.28M
EBIT after Unusual Expense
317.56M 224.91M 158.80M 51.03M
Non Operating Income/Expense
(4.37M) (10.59M) (1.51M) 765.40K
Non-Operating Interest Income
- 2.29M 3.77M 4.85M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
20.49M 22.50M 40.45M 40.57M
Interest Expense Growth
-62.29% +9.84% +79.78% +0.28%
Gross Interest Expense
20.49M 22.50M 40.45M 40.57M
Interest Capitalized
- - - -
-
Pretax Income
292.70M 191.81M 116.84M 11.23M
Pretax Income Growth
+216.14% -34.47% -39.09% -90.39%
Pretax Margin
+23.59% +15.94% +10.60% +1.12%
Income Tax
45.21M 36.70M 29.90M 5.49M
Income Tax - Current - Domestic
42.61M 31.77M 20.86M 2.04M
Income Tax - Current - Foreign
5.87M 5.17M 8.04M 4.85M
Income Tax - Deferred - Domestic
(3.28M) (240.67K) 1.01M (1.40M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
247.49M 155.11M 86.94M 5.74M
Minority Interest Expense
- - - -
-
Net Income
247.49M 155.11M 86.94M 5.74M
Net Income Growth
+430.88% -37.33% -43.95% -93.40%
Net Margin Growth
+19.95% +12.89% +7.89% +0.57%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
247.49M 155.11M 86.94M 5.74M
Preferred Dividends
- - - -
-
Net Income Available to Common
247.49M 155.11M 86.94M 5.74M
EPS (Basic)
0.2475 0.155 0.0884 0.006
EPS (Basic) Growth
+431.12% -37.37% -42.97% -93.21%
Basic Shares Outstanding
1.00B 1.00B 983.50M 962.30M
EPS (Diluted)
0.2468 0.1549 0.0882 0.0059
EPS (Diluted) Growth
+429.61% -37.24% -43.06% -93.31%
Diluted Shares Outstanding
1.00B 1.00B 985.60M 974.10M
EBITDA
367.96M 294.82M 249.64M 170.05M
EBITDA Growth
+21.56% -19.88% -15.33% -31.88%
EBITDA Margin
+29.66% +24.49% +22.65% +16.92%

Dr. Martens Plc in the News